Syra Health Corp. (NASDAQ:SYRA – Get Free Report) was the recipient of a significant decline in short interest in October. As of October 31st, there was short interest totalling 166,600 shares, a decline of 20.0% from the October 15th total of 208,200 shares. Based on an average daily trading volume, of 213,500 shares, the days-to-cover ratio is presently 0.8 days. Approximately 2.2% of the shares of the stock are short sold.
Syra Health Stock Down 4.1 %
SYRA stock traded down $0.02 on Friday, reaching $0.36. 221,373 shares of the company’s stock were exchanged, compared to its average volume of 769,699. The stock has a fifty day moving average of $0.44 and a 200-day moving average of $1.02. The firm has a market cap of $3.48 million and a PE ratio of -0.55. Syra Health has a twelve month low of $0.34 and a twelve month high of $8.37.
Syra Health (NASDAQ:SYRA – Get Free Report) last posted its quarterly earnings results on Tuesday, October 29th. The company reported ($0.06) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.15. Syra Health had a negative net margin of 54.90% and a negative return on equity of 131.94%. The business had revenue of $2.25 million for the quarter, compared to analysts’ expectations of $1.99 million. During the same period in the prior year, the company posted ($0.08) EPS. On average, equities research analysts predict that Syra Health will post -0.53 EPS for the current fiscal year.
Syra Health Company Profile
Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions.
Featured Stories
- Five stocks we like better than Syra Health
- Where to Find Earnings Call Transcripts
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- How to Evaluate a Stock Before BuyingÂ
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- How to Calculate Inflation Rate
- Time to Load Up on Home Builders?
Receive News & Ratings for Syra Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syra Health and related companies with MarketBeat.com's FREE daily email newsletter.